Driving the future of health

Morgan Stanley highlights Research Grid as a startup tackling gender health disparities

Morgan Stanley explores the women’s health gap and how tech startups like Research Grid are helping women achieve better health outcomes.

Research Grid founder and CEO spotlighted as one of 11 early-stage founders scaling their innovations

Research Grid founder and CEO Dr Amber Hill is one of 11 EMEA-based founders to be selected for the latest cohort of Morgan Stanley’s Inclusive Ventures Lab.

Research Grid Selected for Morgan Stanley's Inclusive Ventures Lab

Research Grid was one of 25 startups chosen globally for Morgan Stanley’s in-house accelerator.

Research Grid founder and CEO discusses the power of AI in clinical research with the Wall Street Journal

Our CEO Dr Amber Hill shares her insights on how AI-driven approaches to data management can deliver sustainable top-line growth in clinical research.

How Research Grid supports the full potential of AI in drug development

AI is rapidly advancing drug discovery. However, the focus is shifting towards the next frontier: AI-driven clinical trials. Research Grid’s solutions are one way that researchers can incorporate AI into their workflow to make their trials faster and more successful.

Research Grid's Insights Into Major Developments in Clinical Trials and Community Engagement

In recent months, there have been major events in the UK, Europe, and the US that are reshaping clinical trials and community engagement. The contributions of companies like Research Grid will be crucial in achieving the goals set forth in these recent developments.

We use some essential cookies to make this service work. We’d also like to use analytics cookies so we can understand how you use the service and make improvements. If you agree to the use of all functional cookies, click “Accept Cookies”. If you wish to only allow the use of essential cookies, click “Reject Cookies”. For more information, read our Cookie Policy here.